This site is intended for healthcare professionals only
LoginRegister
Govt Panel Drops Plan to Ban Ads on Schedule G Drugs, Cites Alternative ApproachHimachal companies under scanner: Substandard medicines trigger notices, recalls
Bharat Biotech, Biofabri ink technology transfer deal for TB vaccine MTBVACBharat Biotech, Biofabri ink technology transfer deal for TB vaccine MTBVAC
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreAurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore
Pill form of Wegovy gets USFDA approval for weight lossPill form of Wegovy gets USFDA approval for weight loss
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Biologics gains full gobal rights to biosimilar Adalimumab
Sanofi India appoints Haresh Vala as Company Secretary, Compliance OfficerSanofi-Regeneron Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Amid Global Headwinds, Brazil and Nigeria Fuel Indias Pharma Export GrowthPLI Schemes reduce API import dependence: Govt tells Parliament
Azithromycin, Ofloxacin Combos Among 3 Drug Batches Flagged as Purportedly Spurious by CDSCOCDSCO Flags Popular Pantoprazole, Telmisartan Batches as Spurious in November Alert
GSK to Acquire RAPT Therapeutics for USD 2.2 Billion, Bolsters Food Allergy Drug PipelineGSK Pharma Slapped Rs 38.06 Cr Decree by Bombay Court in Legacy Property Dispute
Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss EntryRoche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma
CDSCO Panel Declines to Consider ACME Generics Phase IV Trial Results for Liothyronine TabletsCDSCO Panel Declines to Consider ACME Generics' Phase IV Trial Results for Liothyronine Tablets
Haryana CGST Arrests Pharma Trader Over Rs 21 Cr Tax EvasionHaryana CGST Arrests Pharma Trader Over Rs 21 Cr Tax Evasion
X